Biotech
Human history has been all but defined by death and disease, plague and pandemic. Advancements in 20th century medicine changed all of that. Now advancements in 21st century medicine promise to go even further. Could we bring about an end to disease? Reverse aging? Give hearing to the deaf and sight to the blind? The answer may be yes. And soon.
More
Open-source COVID-19 saliva test could be a game changer
SalivaDirect, a COVID-19 saliva test funded by the NBA and NBA players’ union, could be the cheap, accurate testing method the U.S. desperately needs.
This smart pill could unlock mysteries of the human gut
A new smart pill can be programmed to collect gut microbiome samples from anywhere along the GI tract — overcoming a major research problem.
AI force plate prevents injuries by predicting them
Sparta Science has developed an AI-powered force plate system that prevents injuries among athletes and soldiers by predicting their likelihood.
Doctors spray chemo inside abdominal cancer patients
For the first time, a U.S. trial will test the ability of an experimental cancer treatment called PIPAC to help late-stage abdominal cancer patients.
Immune proteins show promise as COVID-19 treatment
Immune proteins called interferons appear useful as a COVID-19 treatment if given to patients before an infection becomes severe.
Good news, bad news, and reasons to be optimistic about COVID-19
Much has evolved since the earliest predictions about COVID-19. Here’s how the data is updating our view on the coronavirus.
Gates Foundation backs a $3 coronavirus vaccine
The Gates Foundation is spending $150 million to help with the manufacturing and distribution of a $3 coronavirus vaccine in lower-income nations.
Urine test could replace malignant melanoma biopsies
Doctors can look to the levels of certain fluorescent molecules in the urine of malignant melanoma patients to track the progression of their skin cancer.
Gene-edited squid: a breakthrough in brain health research
Researchers use CRISPR to create a gene-edited squid. This work could help advance research on neurodegenerative diseases like Huntington’s or Alzheimer’s.
App brings psychedelic-assisted therapy into your home
The Field Trip app aims to help people get some of the benefits of psychedelic-assisted therapy outside the confines of a clinic.
Is it safe to fly right now? MIT expert weighs in.
Is it safe to fly right now? An MIT professor calculated the risk of air travel during the pandemic in two different flight scenarios.
One ayahuasca experience could have lasting effects on the brain
Researchers believe just one ayahuasca experience may be enough to have a lasting effect on the brain.
Nerve-stimulating earbud could accelerate language learning
A non-invasive vagus nerve stimulation device can make language learning easier — and it might help with other types of learning, too.
Researchers create blueprint for the “love hormone” receptor
The shape of the love hormone receptor is finally revealed in a 3D map created by researchers at the University of Zurich.
Hack your dreams to improve your waking life
These scientists want to hack your dreams to improve your creativity and memory.
Medieval medicine yields modern weapons
Deadly antibiotic-resistant superbugs require new weapons. Ancient and medieval medicine may point us to where to find them.
Designer antibodies could help treat and prevent COVID-19
A pair of new trials will test the ability of designer antibodies to not only treat COVID-19, but also potentially prevent coronavirus infections.
Afghan farmers use solar panels to grow food — and opium
Farmers in Afghanistan are taking advantage of cheap solar panels to power the water pumps they use to irrigate crops for food and opium production.
How thread became critical in a pandemic
Tech giants have teamed up to help innovate the PPE supply chain and lessen the risk of future shortages, starting with the world’s leading thread supplier.
Updated coronavirus vaccine list: Where we stand today
A regularly updated coronavirus vaccine list highlighting the candidates closest to receiving approval from regulators.
Subscribe to the newsletter